Li, H.; Tang, Y.; Hua, L.; Wang, Z.; Du, G.; Wang, S.; Lu, S.; Li, W.
A Systematic Pan-Cancer Analysis of MEIS1 in Human Tumors as Prognostic Biomarker and Immunotherapy Target. J. Clin. Med. 2023, 12, 1646.
https://doi.org/10.3390/jcm12041646
AMA Style
Li H, Tang Y, Hua L, Wang Z, Du G, Wang S, Lu S, Li W.
A Systematic Pan-Cancer Analysis of MEIS1 in Human Tumors as Prognostic Biomarker and Immunotherapy Target. Journal of Clinical Medicine. 2023; 12(4):1646.
https://doi.org/10.3390/jcm12041646
Chicago/Turabian Style
Li, Han, Ying Tang, Lichun Hua, Zemin Wang, Guoping Du, Shuai Wang, Shifeng Lu, and Wei Li.
2023. "A Systematic Pan-Cancer Analysis of MEIS1 in Human Tumors as Prognostic Biomarker and Immunotherapy Target" Journal of Clinical Medicine 12, no. 4: 1646.
https://doi.org/10.3390/jcm12041646
APA Style
Li, H., Tang, Y., Hua, L., Wang, Z., Du, G., Wang, S., Lu, S., & Li, W.
(2023). A Systematic Pan-Cancer Analysis of MEIS1 in Human Tumors as Prognostic Biomarker and Immunotherapy Target. Journal of Clinical Medicine, 12(4), 1646.
https://doi.org/10.3390/jcm12041646